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Summary
The aim of this pilot project was to inves-
tigate association of viruses with bacterial 
biofilms. Our preliminary data indicate that 
important viral pathogens of swine, namely, 
porcine reproductive and respiratory syn-
drome virus and porcine circovirus type 2, 
can associate with and persist within bacte-
rial biofilms for several days.
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Resumen - Persistencia del virus del sín-
drome reproductivo y respiratorio porcino 
(PRRSV por sus siglas en inglés) y del 
circovirus porcino tipo 2 (PCV2 por sus 
siglas en inglés) en biofilms bacterianos
La meta de este proyecto piloto fue inves-
tigar la asociación de virus con biofilms 
bacterianos. Nuestra información preliminar 
indica que importantes patógenos virales 
porcinos, o sea, virus del síndrome reproduc-
tivo y respiratorio y circovirus porcino tipo 
2, pueden asociarse y persistir dentro de los 
biofilms bacterianos por varios días. 
Résumé - Persistance du virus du syn-
drome reproducteur et respiratoire porcin 
(VSRRP) et du circovirus porcin de type 2 
(CVP2) dans des biofilms bactériens
Le but de ce projet pilote était d’examiner 
l’association de virus avec des biofilms bacté-
riens. Nos données préliminaires indiquent 
que des virus pathogènes importants chez 
le porc, en particulier le virus du syndrome 
reproducteur et respiratoire porcin et le 
circovirus porcin de type 2, peuvent être 
associés et persister pendant plusieurs jours à 
l’intérieur de biofilms bactériens.
 
Bacterial biofilms are structured clus-ters of bacterial cells that are enclosed in a self-produced polymer matrix 
and attached to a surface.1,2 Biofilms protect 
bacteria and allow them to survive and thrive 
under hostile environmental conditions. 
Bacteria within a biofilm are usually more 
resistant to elimination by immune cells and 
to the action of antibiotics and disinfectants. 
The latter represents an important problem 
for the food industry.3
The biofilm polymer matrix might also be 
able to protect viruses. It has been reported4 
that the largemouth bass virus can associate 
with biofilms produced by environmental 
strains of Pseudomonas, and consequently 
the virus is protected against certain chemi-
cal disinfectants. Moreover, biofilms in 
drinking-water distribution systems can 
become reservoirs for pathogens, including 
enteric viruses.5 We thus hypothesized that 
important viral pathogens of swine can 
associate with bacterial biofilms and persist 
for long periods in the environment of swine 
farms. The aims of this pilot project were to 
investigate the association of two important 
viral pathogens of swine, namely, porcine 
reproductive and respiratory syndrome virus 
(PRRSV; an enveloped virus) and porcine 
circovirus type 2 (PCV2; a non-enveloped 
virus) with bacterial biofilms, and to deter-
mine whether bacterial biofilms can protect 
PCV2 against disinfectants.
Materials and methods
Bacterial biofilms
A standard microtiter plate assay for biofilm 
formation that is routinely used in our labo-
ratory, and which involves staining biofilms 
with crystal violet, was performed.6 First, 
biofilms of enteric bacterial pathogens (Esch-
erichia coli strain ECL 17608 or Salmonella 
Typhimurium strain ATCC 14028) and 
respiratory bacterial pathogens (Actinobacil-
lus pleuropneumoniae serotype 1 strain 719 
or Streptococcus suis serotype 2 strain 735 
and non-typeable strain 1097925) were 
established in vitro following an incubation 
of 24 to 72 hours. The growth conditions 
enabling optimal biofilm formation for these 
bacterial strains have been already deter-
mined in our laboratory.7-9 In some experi-
ments, biofilms were visualized by confocal 
laser scanning microscopy.7
Persistence of PRRSV and PCV2 in 
bacterial biofilms
A defined amount of a virus preparation 
(PRRSV genotype 2 reference strain IAF-
Klop, 103.0 median tissue culture infective 
doses [TCID50] per well; or PCV2b strain 
FMV06-0732, 104.5 TCID50 per well) 
was added to the culture of each of the five 
named bacterial pathogens and incubated 
in a standard microtiter plate assay for bio-
film formation. The persistence of the viral 
genome was monitored for up to 3 days in 
both the supernatant (ie, the liquid phase 
above the biofilm) and the biofilm attached 
at the bottom of the well. Virus-specific 
quantitative polymerase chain reaction 
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(qPCR) and reverse-transcriptase qPCR 
(RT-qPCR) assays were performed accord-
ing to standardized protocols used by the 
Diagnostic Services (Faculté de médecine 
vétérinaire, Université de Montréal), namely, 
an in-house assay for PCV210 and a com-
mercial kit for PRRSV (EZ-PRRSV MPX 
4.0; Tetracore, Rockville, Maryland). The 
qPCR and RT-qPCR results were expressed 
in TCID50 per mL after arithmetically 
comparing them to standard curves previ-
ously established with infectious PRRSV 
and PCV2 titrated in cell cultures. Since a 
positive qPCR result does not necessarily 
correlate with infectious potential, viral 
infectious titers were also determined using 
specific permissive cell culture models: 
MARC-145 for PRRSV11 and NPTr12 for 
PCV2 (a new cell line permissive to PCV2; 
unpublished data). Bacterial cells were 
removed by filtration on a 0.22-μm pore 
size membrane (UFC30GVOS; EMD Mil-
lipore, Mississauga, Ontario, Canada) before 
titration. The amount of infectious virus 
was calculated from a 96-well microplate of 
infected cells by the Kärber method, and the 
results were expressed in TCID50 per mL.10 
The survival of the virus within a biofilm was 
arithmetically compared to the survival of an 
equal amount of virus in a microtiter plate 
well in the absence of a biofilm.
PCV2 susceptibility to disinfectants 
in the presence of bacterial biofilms
In addition to evaluating viral persistence 
within bacterial biofilms, this study also 
determined whether bacterial biofilms 
can protect PCV2 (a non-enveloped virus 
known to be more resistant than PRRSV, 
an enveloped virus) against disinfectants. 
Porcine circovirus type 2 virions, in the 
presence or absence of A pleuropneumoniae 
biofilms, were exposed for 30 minutes to 
several classes of disinfectants routinely 
used on farms at the concentrations recom-
mended by the manufacturers (1% acid 
peroxygen; Virkon, Vétoquinol, Lavaltrie, 
Quebec, Canada; and 1% quaternary 
ammonium-glutaraldehyde; Aseptol 2000, 
S.E.C. Repro Inc, Ange-Gardien, Quebec, 
Canada). A virus-specific qPCR assay could 
not be used in these experiments, since a 
positive qPCR does not correlate with infec-
tious potential. The infectious viral titers 
were thus determined using the appropriate 
cell line as described. To ensure that residual 
disinfectant did not interfere with the assay, 
excess disinfectant was removed by ultracen-
trifugation at 100,000g for 1 hour, and the 
virus pellet was resuspended in water to the 
initial volume. The viability of the bacterial 
cells within the biofilm was also evaluated 
after exposure to the disinfectants using the 
CellTiter-Blue cell viability assay (Promega, 
Madison, Wisconsin).
Results
Persistence of PRRSV and PCV2 in 
bacterial biofilms
An example of a bacterial biofilm formation 
is shown in Figure 1. Results of monitoring 
the presence of PRRSV for up to 3 days 
using a virus-specific qPCR assay are pre-
sented in Table 1. A small proportion of the 
viral inoculum persisted in the biofilms for 
the duration of the experiment; this amount 
was considered too small, however, to attempt 
quantification of infectious viruses by titra-
tion on the MARC-145 cell line. For exam-
ple, the amount of PRRSV recovered from 
the E coli biofilm was 16 to 44 TCID50 per 
mL for all time points tested, compared to a 
much greater amount in positive control wells 
(4831 to 5880 TCID50 per mL). Results of 
monitoring for the presence of PCV2b using 
the qPCR assay showed, again, that a portion 
of the viral inoculum persisted in the biofilms 
for the duration of the experiment (Table 2). 
These viruses were infectious when inoculated 
onto NPTr cells (data not shown).
PCV2 susceptibility to disinfectants 
in the presence of bacterial biofilms
In the second set of experiments, a defined 
amount of PCV2b virus strain FMV06-0732 
was added to a culture of A pleuropneumoniae, 
assayed for biofilm formation, and subse-
quently treated with disinfectants. Results 
showed that PCV2b titers were lower in the 
presence of each disinfectant than in the neg-
ative control (ie, wells without disinfectants) 
and that the efficacy of the disinfectants 
against PCV2b was only slightly lower in the 
presence of the A pleuropneumoniae biofilm 
than in the control (Table 3).
Figure 1: Confocal laser scanning microscopic image of a biofilm of Actinobacillus 
pleuropneumoniae, an important bacterial swine pathogen. This is a top view of 
a biofilm formed at the bottom of a microtiter plate well after an incubation of 5 
hours. The biofilm was stained with wheat germ agglutinin (WGA)-Oregon Green 
488, a lectin that binds to poly-N-acetylglucosamine in the biofilm matrix.
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Results of experiments using the CellTiter-
Blue cell viability assay to test the antibacte-
rial efficacy of both disinfectants against 
A pleuropneumoniae biofilms clearly indicated 
that both disinfectants were effective to 
decrease the metabolic activity of A pleu-
ropneumoniae under the study conditions.
Overall, metabolic activity was lower by 90% 
to 100% in the biofilm samples treated with 
disinfectants than in the non-treated samples 
(data not shown), suggesting that large num-
bers of bacterial cells had died. It is important 
to note that the disinfectants killed the bacte-
rial cells but did not remove the biofilms.
Discussion
The effects of biofilms of enteric (E coli 
or Salmonella) or respiratory (A pleuro-
pneumoniae or S suis) bacterial pathogens 
on PRRSV and PCV2, two of the most 
important viruses in the swine industry, 
were studied. Several control experiments 
were conducted prior to initiating this pilot 
project to evaluate, for example, methods for 
virus recovery from a bacterial biofilm, or to 
ensure that no traces of disinfectant were left 
that would affect the cell lines used for viral 
titration. Overall, our results indicate that a 
small portion of the viral inoculum persisted 
in the biofilms for the duration of the experi-
ments, as first determined by qPCR. The 
amount of PRRSV was too small to attempt 
infectious virus quantification by titration on 
MARC-145 cell lines. However, the amount 
of PCV2 was greater, and viral titration on 
NPTr cells was performed, confirming that a 
proportion of the PCV2 inoculum persisted 
in the biofilms and remained infectious. A 
recent publication13 indicated that binding 
of an enteric virus (poliovirus) to bacterial 
polysaccharides stabilizes the virions and 
may offer a selective advantage by enhancing 
environmental stability.
Although the amounts of virus persisting in 
bacterial biofilms were relatively low for one 
of the tested viruses (namely, PRRSV), there 
was a possibility that once incorporated in 
a biofilm, these viruses would be protected 
from disinfectants. Our preliminary results 
Table 1: Results of PCR testing for PRRSV in biofilms of Actinobacillus pleuropneumoniae, Escherichia coli, Salmonella, and 
Streptococcus suis
TCID50 of PRRSV/mL
24 hours 48 hours 72 hours
A pleuropneumoniae Supernatant 359 2109 858
Biofilm 27 14 4
Positive control† 2427 4024 685
Negative control† 0 0 0
E coli Supernatant 5758 4409 3214
Biofilm 16 14 44
Positive control† 4831 5292 5880
Negative control† 0 0 0
Salmonella Supernatant 252 344 219
Biofilm 21 28 53
Positive control† 1464 3329 3622
Negative control† 0 0  0
S suis Supernatant 2487 2828 2638
735‡ Biofilm 106 67 276
Positive control† 5035 3713 3031
Negative control† 0 0 0
S suis Supernatant 4574 4110 3654
NT1097925§ Biofilm 377 258 256
Positive control† 5035 3713 3031
Negative control† 0 0 0
*  For each organism, the virus suspension was added to a bacterial culture and incubated in a standard microtiter plate assay for biofilm 
formation. Testing for PRRSV was conducted daily, using a commercial PCR kit (EZ-PRRSV MPX 4.0; Tetracore, Rockville, Maryland), for up 
to 3 days in the supernatant (liquid phase above the biofilm) and in the biofilm attached to the plastic surface.
†  Positive control, no bacteria, virus only; negative control, no virus, bacteria only.
‡  This strain produces a biofilm in the presence of fibrinogen.8
§  This strain does not require fibrinogen to produce a biofilm.9
PCR = polymerase chain reaction; PRRSV = porcine reproductive and respiratory syndrome virus; TCID50 = median tissue culture infectious 
dose.
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indicate that bacterial biofilms seem to only 
slightly reduce the efficacy of disinfectants, 
which nevertheless remain effective against 
the virus tested.
To the best of our knowledge, this is the first 
description of the persistence of two impor-
tant swine viral pathogens, PRRSV and 
PCV2b, within bacterial biofilms. This pilot 
project generated preliminary data impor-
tant for the swine industry in a new area that 
certainly deserves to be investigated in more 
detail. It would be relevant to perform simi-
lar experiments with other important swine 
viruses such as the porcine epidemic diarrhea 
virus or the porcine deltacoronavirus.
Table 2: Results of testing for PCV2b in Actinobacillus pleuropneumoniae, 
Escherichia coli, Salmonella, and Streptococcus suis biofilms by virus-specific PCR 
(expressed as TCID50/mL)*
TCID50 of PCV2b/mL
A pleuropneumoniae Supernatant 7.21 × 105
Biofilm 5.63 × 104
Positive control† 9.77 × 105
Negative control† 0
E coli Supernatant 4.99 × 105
Biofilm 5.89 × 104
Positive control† 9.68 × 105
Negative control† 0
Salmonella Supernatant 1.78 × 104
Biofilm 1.74 × 104
Positive control† 7.90 × 105
Negative control† 0
S suis Supernatant 7.71 × 104
735‡ Biofilm 3.57 × 104
Positive control† 3.48 × 105
Negative control† 0
S suis Supernatant 3.41 × 105
NT1097925§ Biofilm 5.15 × 104
Positive control† 3.48 × 105
Negative control† 0
*  The virus suspension was added to a bacterial culture and incubated in a standard 
microtiter plate assay for biofilm formation for 24 hours for A pleuropneumoniae, E coli, 
and S suis, and for 48 hours for Salmonella in order to achieve optimal biofilm formation. 
The presence of the virus was determined for up to 2 days in the supernatant (liquid 
phase above the biofilm) and in the biofilm attached to the plastic surface.
†  Positive control: no bacteria, virus only; negative control, no virus, bacteria only.
‡  This strain produces a biofilm in the presence of fibrinogen.8
§  This strain does not require fibrinogen to produce a biofilm.9 
PCV2b = porcine circovirus type 2b; PCR = polymerase chain reaction; TCID50 = median 
tissue culture infectious dose.
Implications
•	 PRRSV	and	PCV2	can	associate	with	
bacterial biofilms that are known to be 
present inside the infected host or in 
the farm’s environment.
•	 PRRSV	and	PCV2	can	persist	within	
Gram-positive and Gram-negative 
bacterial biofilms for several days.
•	 Under	the	conditions	of	this	study,	
the efficacy of acid peroxygen and 
quaternary ammonium-glutaraldehyde 
commercial disinfectants against PCV2 
may be only slightly reduced by the 
presence of a bacterial biofilm.
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